surmount 2 tirzepatide once weekly for the treatment of obesity in people with type diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial The Surmount Program. TZP, Tirzepatide; – ECO 2026: SURMOUNT-MAINTAIN proves tirzepatide

For that price you get four lab panels a year, 500+ daily signals from your wearables, a 24/7 AI Health Coach, custom supplements formulated from your results, and prescription access through licensed clinicians, with your protocol adjusted every 90 days

But GLP-1 medications arent approved for use in people whose body mass index, or BMI, falls below 27

The honest framing, the one Dr

It's important to understand that even after stopping the medication, delayed gastric emptying may persist in some individuals

Deciding to go booze-free, even for a short stint of time, can be a wise decision for our health, our wallets, and even our relationships